Inventor · disambiguated record
Douglas Campbell
Also filed as: CAMPBELL DOUGLAS · CAMPBELL DOUGLAS A · CAMPBELL DOUGLAS H
7 granted patents·14 pending applications·89 citations·filing 2000–2023
83Inventor score
Files withMINOMIC INT LTD9CAMPBELL DOUGLAS A7DARMATE GLASSWORKS LLC2GLYP HOLDINGS PTY LTD1NURCOMBE VICTOR1
Top patents by PatentIndex Score
21 records- 0186US7209959B1Apparatus, system, and method for communicating to a network through a virtual domain providing anonymity to a client communicating on the networkWK NETWORKS INC·Filed 2000·Granted Apr 24, 2007·59 cites·26 claims
- 0286US7022486B2Peptide sequence tags and method of using sameCAMPBELL DOUGLAS A·Filed 2002·Granted Apr 4, 2006·23 cites·2 claims
- 0368US8370457B2Network communication through a virtual domainDARMATE GLASSWORKS LLC·Filed 2007·Granted Feb 5, 2013·4 cites·24 claims
- 0468US2024247037A1Glypican epitopes and uses thereofMINOMIC INT LTD·Filed 2023·Application pending·0 cites
- 0562US10577418B2Monoclonal anti-GPC-1 antibodies and uses thereofGLYP HOLDINGS PTY LTD·Filed 2014·Granted Mar 3, 2020·2 cites·13 claims
- 0659US10151754B2Cell surface prostate cancer antigen for diagnosisMINOMIC INT LTD·Filed 2015·Granted Dec 11, 2018·1 cites·18 claims
- 0757US2006127365A1Method of cell therapy using fused cell hybridsNURCOMBE VICTOR·Filed 2003·Application pending·0 cites
- 0855US2021107958A1Glypican epitopes and uses thereofMINOMIC INT LTD·Filed 2020·Application pending·0 cites
- 0952US2006099663A1Peptide sequence tags and method of using sameCAMPBELL DOUGLAS A·Filed 2005·Application pending·0 cites
- 1049US2019120846A1Cell surface prostate cancer antigen for diagnosisMINOMIC INT LTD·Filed 2018·Application pending·0 cites
- 1148US8762498B2Apparatus, system, and method for communicating to a network through a virtual domainDARMATE GLASSWORKS LLC·Filed 2012·Granted Jun 24, 2014·0 cites·20 claims
- 1248US2006094072A1Peptide sequence tags and method of using sameCAMPBELL DOUGLAS A·Filed 2005·Application pending·0 cites
- 1348US2006094058A1Peptide sequence tags and method of using sameCAMPBELL DOUGLAS A·Filed 2005·Application pending·0 cites
- 1448US2023305009A1Biomarker combinations for determining aggressive prostate cancerMINOMIC INT LTD·Filed 2021·Application pending·0 cites
- 1543US2018002391A1Glypican epitopes and uses thereofMINOMIC INT LTD·Filed 2015·Application pending·0 cites
- 1641US2023333111A1Biomarker combinations for determining aggressive prostate cancerMINOMIC INT LTD·Filed 2019·Application pending·0 cites
- 1739US2006160141A1Peptide sequence tags and method of using sameCAMPBELL DOUGLAS A·Filed 2006·Application pending·0 cites
- 1838US2006148004A1Peptide sequence tags and method of using sameCAMPBELL DOUGLAS A·Filed 2006·Application pending·0 cites
- 1938US2006148003A1Peptide sequence tags and method of using sameCAMPBELL DOUGLAS A·Filed 2006·Application pending·0 cites
- 2033US11198738B2Therapeutic antibodies and uses thereofMINOMIC INT LTD·Filed 2016·Granted Dec 14, 2021·0 cites·9 claims
- 2129US2018224454A1Biomarker combinations for prostate diseaseMINOMIC INT LTD·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Douglas Campbell files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →